{"product_id":"ceftisol-50-mg-ml-ceftiofur-cattle-and-pigs-bovini-e-suini","title":"CEFTISOL 50 mg\/ml \/\/ Ceftiofur \/\/ cattle and pigs \/ bovini e suini","description":"\u003cdiv class=\"w-layout-cell cell-3\"\u003e\n\u003cdiv class=\"div-block-21\"\u003e\n\u003ch4 class=\"heading-2\"\u003e\u003cstrong\u003e\u003cspan\u003eDirections\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cdiv class=\"product-rich-text w-richtext\"\u003e\n\u003cp\u003e\u003cspan\u003eIn cattle and pigs for the treatment of respiratory diseases caused by microorganisms sensitive to ceftiofur.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn cattle for the treatment of interdigital necrobacillosis and postpartum metritis. The recommendation is limited to those cases of metritis in which treatment with another anti-microbial substance has not proven effective. It is effective against the following bacteria:\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eBovine\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e : \u003c\/span\u003e\u003cem\u003e\u003cspan\u003ePasteurella haemolytica, P. multocida, Haemophilus somnus, Fusobacterium necrophorum, Bacteroides melaninogenicus.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePorcine\u003c\/strong\u003e:\u003cspan\u003e \u003c\/span\u003e\u003cem\u003eActinobacillus pleuropneumoniae, Pasteurella multocida, Salmonella choleraesuis, Streptococcus suis.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"w-layout-cell\"\u003e\n\u003cdiv class=\"med-image\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"w-node-_6906d709-f081-b9d1-09fb-31ac0e8a98db-daab23cd\" class=\"w-layout-cell\"\u003e\n\u003cdiv class=\"product-rich-text w-richtext\"\u003e\n\u003ch4\u003e\u003cstrong\u003e\u003cspan\u003eCOMPOSITION\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cspan\u003eCeftiofur (as hydrochloride) ..... 50 mg\/ml\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e‍\u003c\/p\u003e\n\u003ch4\u003e\u003cstrong\u003e\u003cspan\u003eCONTRAINDICATIONS\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cspan\u003eDo not use in animals with known hypersensitivity to ceftiofur or other β-lactam antibiotics. Do not administer intravenously. Do not use in cases of resistance to other cephalosporins or β-lactam antibiotics. Do not use in poultry (including egg-producing birds) due to the risk of antimicrobial resistance in humans.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch4\u003e\u003cstrong\u003e\u003cspan\u003eADVERSE REACTIONS\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cspan\u003eHypersensitivity reactions may occur regardless of the dose used. Very rarely (less than 1 animal in 10,000 animals treated, including isolated reports) allergic reactions (e.g. skin reactions, anaphylaxis) may occur.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cem\u003e\u003cspan\u003ePigs\u003c\/span\u003e\u003c\/em\u003e\u003cspan\u003e :\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Slight discoloration may occur at the injection site in the fascia and adipose tissue for at least 20 days after administration.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cem\u003e\u003cspan\u003eCattle\u003c\/span\u003e\u003c\/em\u003e\u003c\/strong\u003e\u003cspan\u003e : A mild reaction, temporary swelling and subsequent discolouration of the connective tissue and fascia may occur at the injection site, which generally resolves within 10 days. Slight tissue discolouration may persist for up to 28 days. Mild to moderate swelling was observed in most animals for 42 days after treatment. Injection site reactions have been reported very rarely in the field.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e \u003c\/strong\u003e\u003c\/p\u003e\n\u003ch4\u003e\u003cstrong\u003e\u003cspan\u003eDOSAGE FOR EACH SPECIES, ROUTE AND METHOD OF ADMINISTRATION\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cspan\u003eTo avoid underdosing, it is necessary to determine the body weight of the animals as accurately as possible.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePorcine\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e3 mg ceftiofur \/ kg body weight (1 ml CEFTISOL \/ 16 kg body weight), administered intramuscularly once a day, for three consecutive days.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eNo more than 4 ml should be administered at the injection site.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBovine\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn case of respiratory infections: 1 mg ceftiofur \/ kg body weight, (1 ml CEFTISOL \/ 50 kg body weight) administered subcutaneously once a day, for 3-5 consecutive days.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eFor the treatment of acute interdigital necrobacillosis: 1 mg ceftiofur\/kg body weight (1 ml CEFTISOL\/50 kg body weight) administered subcutaneously once daily for 5 consecutive days.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn case of acute postpartum metritis within 10 days after calving, 1 mg ceftiofur \/ kg body weight (1 ml CEFTISOL \/ 50 kg body weight), administered subcutaneously once a day for 5 consecutive days.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eNo more than 13 ml should be administered at the injection site.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e \u003c\/strong\u003e\u003c\/p\u003e\n\u003ch4\u003e\u003cstrong\u003e\u003cspan\u003eRECOMMENDATIONS ON CORRECT ADMINISTRATION\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cspan\u003eBefore use, shake the bottle well for at least 60 seconds or until the product has a homogeneous appearance.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eSubsequent administrations should be applied at different sites.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe 50 and 100 ml bottles should be punctured no more than 50 times. The 250 ml bottles should be punctured no more than 33 times. In other cases, the use of a multidose syringe is recommended. In some cases, complementary therapy may be necessary in the treatment of acute postpartum metritis.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch4\u003e\u003cstrong\u003e\u003cspan\u003eWAITING TIMES\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003ePork\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e (meat and offal): 2 days\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eCattle\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e (meat and offal): 6 days\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eMilk\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e : 0 days.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch4\u003e\u003cstrong\u003e\u003cspan\u003eSPECIAL STORAGE PRECAUTIONS\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cspan\u003eKeep out of sight and reach of children.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eDo not store above 25ºC.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eStore in the original packaging.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eProtect from direct light.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eDo not use after the expiry date stated on the label.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e \u003c\/strong\u003e\u003c\/p\u003e\n\u003ch4\u003e\u003cstrong\u003e\u003cspan\u003eVALIDITY PERIOD\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cspan\u003eShelf life of the veterinary medicinal product as packaged for sale: 2 years.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eShelf life after first opening the immediate packaging: 28 days. \u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch4\u003e\u003cstrong\u003e\u003cspan\u003eSPECIAL WARNINGS\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eSpecial precautions for use in animals\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eCEFTISOL selects for resistant strains, such as bacteria secreting extended-spectrum beta-lactamases (ESBLs) and could pose a risk to human health if these strains were to spread to humans, for example through food. For this reason, CEFTISOL should be reserved for the treatment of clinical conditions that have responded inadequately or are expected to respond inadequately (referring to very acute cases where treatment must be initiated without bacteriological diagnosis) to first-line treatment. Official, national and regional antimicrobial policies should be taken into account when using the product. Frequent use, including use of the product deviating from the instructions provided in the SPC, may increase the prevalence of resistant bacteria. Whenever possible, CEFTISOL should only be used based on susceptibility testing. CEFTISOL is intended for the treatment of individual animals. Do not use for disease prophylaxis or in herd health programmes. Treatment of groups of animals should be strictly limited to current disease outbreaks according to the approved conditions of use. Do not use for prophylactic purposes in case of retained placenta.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eSpecial precautions to be taken by the person administering the veterinary medicinal product to animals\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003ePenicillins and cephalosporins may cause hypersensitivity (allergy) after self-injection, inhalation, ingestion or skin contact. People who are hypersensitive to penicillin may also be hypersensitive to cephalosporins and vice versa. Allergic reactions to these active substances may be serious. People with known hypersensitivity to penicillin or cephalosporins should avoid direct contact with this veterinary medicinal product. All precautions should be taken to avoid direct contact with the product. If symptoms such as skin rash occur after contact with the product, seek medical advice and show the package leaflet or the product label to the physician. Swelling of the face, lips, eyes or difficulty in breathing are serious symptoms and require immediate medical attention.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eUse during pregnancy or lactation \u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAccording to the analyses carried out on laboratory animals, the product has no proven teratogenic, fetotoxic or maternotoxic effect. No studies have been conducted in the target species during gestation and lactation.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eUse only according to the benefit\/risk assessment by the responsible veterinarian.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eInteractions with other medicinal products or other forms of interaction\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe bactericidal effect of β-lactam antibiotics is neutralized by bacteriostatic antibiotics (macrolides, sulfonamides and tetracyclines) administered simultaneously. The effect of cephalosporins can be potentiated by aminoglycosides.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eDOSAGE\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn pigs, the reduced toxicity of ceftiofur was demonstrated by administering 8 times the recommended dose of ceftiofur for 15 days. In cattle, no systemic toxicity symptoms were observed even after parenteral overdoses.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eincompatibility\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn the absence of compatibility studies, this veterinary medicinal product must not be mixed with other veterinary medicinal products.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch4\u003e\u003cstrong\u003e\u003cspan\u003eSPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCT OR WASTE MATERIALS, IF ANY\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cspan\u003eMedicines should not be thrown away via wastewater or household waste. Ask your veterinarian how to dispose of medicines no longer required. These measures help to protect the environment.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cdiv class=\"w-layout-cell cell-3\"\u003e\n\u003cdiv class=\"div-block-21\"\u003e\n\u003ch4 class=\"heading-2\"\u003e\u003cstrong\u003e\u003cspan\u003eIndicazioni\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cdiv class=\"product-rich-text w-richtext\"\u003e\n\u003cp\u003e\u003cspan\u003eNei bovini e nei suini per il trattamento delle malattie respiratorie causate da microrganismi sensibili al ceftiofur.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eNei bovini per il trattamento della necrobacillosi interdigitale e della metrite postpartum. La raccomandazione è limitata ai casi di metrite in cui il trattamento con un'altra sostanza antimicrobica non si è dimostrato efficace. È efficace contro i seguenti batteri:\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eBovini\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e : \u003c\/span\u003e\u003cem\u003e\u003cspan\u003ePasteurella haemolytica, P. multocida, Haemophilus somnus, Fusobacterium necrophorum, Bacteroides melaninogenicus.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eSuini\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e : \u003c\/span\u003e\u003cem\u003e\u003cspan\u003eActinobacillus pleuropneumoniae, Pasteurella multocida, Salmonella choleraesuis, Streptococcus suis.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"w-layout-cell\"\u003e\n\u003cdiv class=\"med-image\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"w-node-_6906d709-f081-b9d1-09fb-31ac0e8a98db-daab23cd\" class=\"w-layout-cell\"\u003e\n\u003cdiv class=\"product-rich-text w-richtext\"\u003e\n\u003ch4\u003e\u003cstrong\u003e\u003cspan\u003eCOMPOSIZIONE\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cspan\u003eCeftiofur (come cloridrato) ..... 50 mg\/ml\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e‍\u003c\/span\u003e\u003c\/p\u003e\n\u003ch4\u003e\u003cstrong\u003e\u003cspan\u003eCONTROINDICAZIONI\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cspan\u003eNon utilizzare in animali con ipersensibilità nota al ceftiofur o ad altri antibiotici β-lattamici. Non viene somministrato per via endovenosa. Non può essere utilizzato in caso di resistenza ad altre cefalosporine o agli antibiotici β-lattamici. Da non utilizzare su pollame (compresi uccelli che producono uova) a causa del rischio di resistenza antimicrobica negli esseri umani.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch4\u003e\u003cstrong\u003e\u003cspan\u003eREAZIONI AVVERSE\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cspan\u003ePossono verificarsi reazioni di ipersensibilità indipendentemente dalla dose utilizzata. Molto raramente (meno di 1 animale su 10.000 animali trattati, compresi i casi isolati) possono verificarsi reazioni allergiche (ad esempio reazioni cutanee, anafilassi).\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cem\u003e\u003cspan\u003eSuini\u003c\/span\u003e\u003c\/em\u003e\u003cspan\u003e :\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e potrebbe verificarsi una leggera decolorazione nel sito di iniezione, nella fascia e nel tessuto adiposo, per almeno 20 giorni dopo la somministrazione.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cem\u003e\u003cspan\u003eBovini\u003c\/span\u003e\u003c\/em\u003e\u003c\/strong\u003e\u003cspan\u003e : nel sito di iniezione può verificarsi una lieve reazione, un'infiammazione temporanea e poi una decolorazione del tessuto connettivo e della fascia, che generalmente si risolve entro 10 giorni. Una leggera decolorazione del tessuto può persistere anche per più di 28 giorni. Nella maggior parte degli animali è stata osservata un'infiammazione da lieve a moderata per 42 giorni dopo il trattamento. Molto raramente sono state segnalate sul campo reazioni nel sito di somministrazione.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e \u003c\/strong\u003e\u003c\/p\u003e\n\u003ch4\u003e\u003cstrong\u003e\u003cspan\u003eDOSAGGIO PER CIASCUNA SPECIE, VIA E MODO DI SOMMINISTRAZIONE\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cspan\u003ePer evitare un sottodosaggio, è necessario determinare il peso corporeo degli animali nel modo più accurato possibile.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eSuino\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e :\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e3 mg di ceftiofur \/ kg di peso corporeo (1 ml di CEFTISOL \/ 16 kg di peso corporeo), somministrati per via intramuscolare una volta al giorno, per tre giorni consecutivi.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eNon somministrare più di 4 ml nel sito di iniezione.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eBovino\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e :\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn caso di infezioni respiratorie: 1 mg di ceftiofur \/ kg di peso corporeo, (1 ml di CEFTISOL \/ 50 kg di peso corporeo) somministrato per via sottocutanea una volta al giorno, per 3-5 giorni consecutivi.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003ePer il trattamento della necrobacillosi interdigitale acuta: 1 mg di ceftiofur\/kg di peso corporeo (1 ml di CEFTISOL\/50 kg di peso corporeo) somministrato per via sottocutanea una volta al giorno per 5 giorni consecutivi.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn caso di metrite acuta postpartum entro 10 giorni dal parto, 1 mg di ceftiofur \/ kg di peso corporeo (1 ml di CEFTISOL \/ 50 kg di peso corporeo), somministrato per via sottocutanea una volta al giorno per 5 giorni consecutivi.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eNon somministrare più di 13 ml nel sito di iniezione.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e \u003c\/strong\u003e\u003c\/p\u003e\n\u003ch4\u003e\u003cstrong\u003e\u003cspan\u003eRACCOMANDAZIONI PER UNA CORRETTA SOMMINISTRAZIONE\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cspan\u003ePrima dell’uso agitare bene il flacone per almeno 60 secondi o comunque fino a quando il prodotto non avrà un aspetto omogeneo.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eLe somministrazioni successive devono essere effettuate in siti diversi.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eLe bottiglie da 50 e 100 ml non potranno essere forate più di 50 volte. Le bottiglie da 250 ml possono essere forate al massimo 33 volte. In altri casi si raccomanda l'uso di una siringa multidose. In alcuni casi, può essere necessaria una terapia complementare nel trattamento della metrite acuta postpartum.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch4\u003e\u003cstrong\u003e\u003cspan\u003eTEMPI DI ATTESA\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eMaiale\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e (carne e frattaglie): 2 giorni\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eBovini\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e (carne e frattaglie): 6 giorni\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eLatte\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e : 0 giorni.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch4\u003e\u003cstrong\u003e\u003cspan\u003ePRECAUZIONI SPECIALI PER LA CONSERVAZIONE\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cspan\u003eTenere fuori dalla vista e dalla portata dei bambini.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eNon conservare a temperatura superiore ai 25ºC.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eConservare nella confezione originale.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eProteggere dalla luce diretta.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eNon utilizzare dopo la data di scadenza riportata sull'etichetta.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e \u003c\/strong\u003e\u003c\/p\u003e\n\u003ch4\u003e\u003cstrong\u003e\u003cspan\u003ePERIODO DI VALIDITÀ\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cspan\u003ePeriodo di validità del medicinale veterinario confezionato per la vendita: 2 anni.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003ePeriodo di validità dopo la prima apertura del confezionamento primario: 28 giorni. \u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch4\u003e\u003cstrong\u003e\u003cspan\u003eAVVERTENZE SPECIALI\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003ePrecauzioni speciali per l'impiego negli animali\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eCEFTISOL seleziona ceppi resistenti, come i batteri che secernono beta-lattamasi a spettro esteso (ESBL), e potrebbero rappresentare un rischio per la salute umana se questi ceppi si diffondessero agli esseri umani, ad esempio tramite gli alimenti. Per questo motivo, CEFTISOL deve essere riservato al trattamento di condizioni cliniche che hanno risposto in modo inadeguato o che si prevede risponderanno in modo inadeguato (riferendosi a casi molto acuti in cui il trattamento deve essere iniziato senza diagnosi batteriologica) al trattamento di prima linea. Quando si utilizza il prodotto, è necessario tenere conto delle norme antimicrobiche ufficiali, nazionali e regionali. L'uso frequente, compreso l'uso del prodotto non conforme alle istruzioni fornite nel riassunto delle caratteristiche del prodotto, può aumentare la prevalenza di batteri resistenti. Ove possibile, CEFTISOL deve essere utilizzato solo sulla base di test di sensibilità. CEFTISOL è destinato al trattamento individuale degli animali. Non utilizzare per la profilassi delle malattie o nei programmi di salute delle mandrie. Il trattamento di gruppi di animali deve essere rigorosamente limitato alle attuali epidemie di malattie, secondo le condizioni d'uso approvate. Non utilizzare a scopo profilattico in caso di ritenzione placentare.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003ePrecauzioni speciali che devono essere adottate dalla persona che somministra il medicinale veterinario agli animali\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eLe penicilline e le cefalosporine possono causare ipersensibilità (allergia) dopo autoiniezione, inalazione, ingestione o contatto con la pelle. Le persone ipersensibili alla penicillina potrebbero esserlo anche alla cefalosporina e viceversa. Le reazioni allergiche scatenate da questi principi attivi possono, in alcuni casi, essere gravi. Le persone con nota ipersensibilità alla penicillina o alla cefalosporina devono evitare il contatto diretto con questo medicinale veterinario. Per evitare il contatto diretto con il prodotto, è necessario osservare tutte le precauzioni. Se dopo il contatto con il prodotto dovessero comparire sintomi, ad esempio eruzioni cutanee, consultare un medico, mostrandogli le istruzioni per l'uso o l'etichetta del prodotto. Gonfiore del viso, delle labbra, degli occhi o difficoltà respiratorie sono sintomi gravi e richiedono cure mediche immediate.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eUtilizzare durante la gravidanza o l'allattamento \u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eSecondo le analisi effettuate sugli animali da laboratorio, il prodotto non ha dimostrato alcun effetto teratogeno, fetotossico o maternotossico. Non sono stati condotti studi sulle specie target durante la gestazione e l'allattamento.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eUtilizzare solo conformemente alla valutazione del rapporto rischio\/beneficio del veterinario responsabile.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eInterazioni con altri medicinali o altre forme di interazione\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eL'effetto battericida degli antibiotici β-lattamici viene neutralizzato dagli antibiotici batteriostatici (macrolidi, sulfonamidi e tetracicline) somministrati contemporaneamente. L'effetto delle cefalosporine può essere potenziato dagli aminoglicosidi.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eDOSAGGIO\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eNei suini, la ridotta tossicità del ceftiofur è stata dimostrata somministrando una dose 8 volte superiore a quella raccomandata per 15 giorni. Nel caso dei bovini, non sono stati osservati sintomi di tossicità sistemica anche dopo sovradosaggi somministrati per via parenterale.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eincompatibilità\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn assenza di studi di compatibilità, questo medicinale veterinario non deve essere miscelato con altri medicinali veterinari.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch4\u003e\u003cstrong\u003e\u003cspan\u003ePRECAUZIONI SPECIALI PER LO SMALTIMENTO DEL PRODOTTO NON UTILIZZATO O DEI RIFIUTI, SE PRESENTI\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cspan\u003eI medicinali non devono essere gettati nelle acque reflue o nei rifiuti domestici. Chiedi al tuo veterinario informazioni su come smaltire i medicinali che non utilizzi più. Queste misure contribuiscono alla tutela dell’ambiente.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Crida Pharm","offers":[{"title":"100 ML","offer_id":50192492036443,"sku":"","price":48.99,"currency_code":"EUR","in_stock":true},{"title":"250 ML","offer_id":50192492069211,"sku":"","price":52.99,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0476\/3261\/3543\/files\/descarcare_4.jpg?v=1741278817","url":"https:\/\/www.petshopluna.com\/en-de\/products\/ceftisol-50-mg-ml-ceftiofur-cattle-and-pigs-bovini-e-suini","provider":"Pet Shop Maya","version":"1.0","type":"link"}